pantoprazole has been researched along with mycophenolic acid in 10 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (40.00) | 29.6817 |
| 2010's | 5 (50.00) | 24.3611 |
| 2020's | 1 (10.00) | 2.80 |
| Authors | Studies |
|---|---|
| Andricopulo, AD; Moda, TL; Montanari, CA | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Bigdeli, AK; Deutsch, MA; Kaczmarek, I; Kofler, S; Meiser, B; Mueller, TH; Reichart, B; Shvets, N; Steinbeck, G; Vogeser, M | 1 |
| Bigdeli, AK; Deutsch, MA; Kaczmarek, I; Kaczmarek, P; Kofler, S; König, MA; Reichart, B; Shvets, N; Steinbeck, G; Vogeser, M | 1 |
| Bucher, M; Faerber, L; Fischer, W; Kees, F; Raspé, A; Rupprecht, K; Schmidt, C; Schweda, F; Shipkova, M | 1 |
| Bönisch-Schmidt, S; Dikow, R; Hug, F; Schaier, M; Scharpf, D; Schmitt, WH; Scholl, C; Schwenger, V; Sommerer, C; Zeier, M | 1 |
| Behr, J; Kaczmarek, I; Kofler, S; Meiser, B; Müller, T; Reichart, B; Shipkova, M; Shvets, N; Sisic, Z; Sohn, HY; Steinbeck, G; Vogeser, M; Wolf, C | 1 |
| Brakemeier, S; Budde, K; Dürr, M; Glander, P; Halleck, F; Hambach, P; Klonower, D; Mai, M; Neumayer, HH; Rissling, O; Schrezenmeier, EV; Singer, E | 1 |
| Boudville, N; Cervelli, M; Chakera, A; Chan, D; Dogra, G; Jeffrey, G; Joyce, D; Lim, WH; Ooi, E; Russ, G; Sallustio, B; Sunderland, A; Wong, G | 1 |
1 review(s) available for pantoprazole and mycophenolic acid
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
4 trial(s) available for pantoprazole and mycophenolic acid
| Article | Year |
|---|---|
Proton pump inhibitor co-medication reduces mycophenolate acid drug exposure in heart transplant recipients.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Drug Interactions; Drug Therapy, Combination; Female; Gastrointestinal Diseases; Heart Transplantation; Humans; Immunosuppressive Agents; Male; Middle Aged; Mycophenolic Acid; Pantoprazole; Proton Pump Inhibitors; Tacrolimus; Treatment Outcome | 2009 |
Bioavailability of mycophenolate mofetil and enteric-coated mycophenolate sodium is differentially affected by pantoprazole in healthy volunteers.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Anti-Ulcer Agents; Biological Availability; Drug Interactions; Female; Glucuronides; Humans; Immunosuppressive Agents; Male; Mycophenolic Acid; Pantoprazole; Tablets, Enteric-Coated; Time Factors | 2009 |
No relevant pharmacokinetic interaction between pantoprazole and mycophenolate in renal transplant patients: a randomized crossover study.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Anti-Ulcer Agents; Cross-Over Studies; Drug Interactions; Enzyme Inhibitors; Female; Glucuronides; Humans; Immunosuppressive Agents; IMP Dehydrogenase; Kidney Transplantation; Male; Middle Aged; Mycophenolic Acid; Pantoprazole; Tablets, Enteric-Coated; Therapeutic Equivalency | 2015 |
Effect of the proton-pump Inhibitor pantoprazole on MycoPhenolic ACid exposure in kidney and liver transplant recipienTs (IMPACT study): a randomized trial.
Topics: Cross-Over Studies; Double-Blind Method; Drug Interactions; Enzyme Inhibitors; Female; Humans; Kidney; Kidney Transplantation; Liver Transplantation; Male; Middle Aged; Mycophenolic Acid; Pantoprazole; Prospective Studies; Proton Pump Inhibitors | 2020 |
5 other study(ies) available for pantoprazole and mycophenolic acid
| Article | Year |
|---|---|
Hologram QSAR model for the prediction of human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Holography; Humans; Models, Biological; Models, Molecular; Molecular Structure; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship | 2007 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Proton pump inhibitors reduce mycophenolate exposure in heart transplant recipients-a prospective case-controlled study.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Acute Disease; Adult; Case-Control Studies; Drug Interactions; Drug Therapy, Combination; Female; Graft Rejection; Heart Transplantation; Humans; Immunosuppressive Agents; Male; Middle Aged; Mycophenolic Acid; Pantoprazole; Prospective Studies; Proton Pump Inhibitors; Risk Factors; Tacrolimus | 2009 |
Proton pump inhibitors interfere with the immunosuppressive potency of mycophenolate mofetil.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Autoimmune Diseases; Chi-Square Distribution; Drug Interactions; Drug Therapy, Combination; Female; Humans; Immunosuppressive Agents; IMP Dehydrogenase; Male; Middle Aged; Mycophenolic Acid; Pantoprazole; Proton Pump Inhibitors; Treatment Outcome | 2010 |
The proton pump inhibitor pantoprazole and its interaction with enteric-coated mycophenolate sodium in transplant recipients.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Area Under Curve; Biological Availability; Drug Interactions; Female; Follow-Up Studies; Graft Rejection; Heart Transplantation; Humans; Immunosuppressive Agents; IMP Dehydrogenase; Lung Transplantation; Male; Middle Aged; Mycophenolic Acid; Pantoprazole; Prospective Studies; Proton Pump Inhibitors; Retrospective Studies; Tablets, Enteric-Coated | 2011 |